A retrospective study of more than 1 million patients admitted to the ICU who underwent echocardiography found that those who received contrast echo were less likely to die within 48 hours compared with those who did not receive the contrast agent. The findings contradict earlier research suggesting echo contrast agents administered to critically ill patients could increase mortality risk.
Contrast echo associated with lower mortality in critically ill patients
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||